Key result
The SAVE ACS classification demonstrated good discrimination for predicting 30-day mortality in patients with acute coronary syndromes (AUC 0.814; 95% CI 0.782-0.845).
Why the study?
The study aimed to identify independent frontline predictors of 30-day mortality in patients with ACS to propose a rapid cardiogenic shock classification and management pathway.
Does the SAVE ACS classification accurately predict 30-day mortality in patients with acute coronary syndromes?
Cohort (n=11,870)
No
Does the SAVE ACS classification accurately predict 30-day mortality in patients with acute coronary syndromes?
Effect estimate: AUC 0.814 (95% CI 0.782-0.845)
The SAVE ACS classification offers a rapid, validated tool using frontline clinical parameters to predict 30-day mortality in patients with acute coronary syndromes.
Introduction. We aimed to identify the independent “frontline” predictors of 30-day mortality in patients with acute coronary syndromes (ACS) and propose a rapid cardiogenic shock (CS) classification and management pathway. Materials and Methods. From 2011 to 2019, a total of 11439 incident ACS patients were treated in our institution. Forward conditional logistic regression analysis was performed to determine the “frontline” predictors of 30 day mortality. The C-statistic assessed the discriminatory power of the model. As a validation cohort, we used 431 incident ACS patients admitted from January 1, 2020, to July 20, 2020. Results. Independent predictors of 30-day mortality included age (OR 1.05; 95% CI 1.04 to 1.07, <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"><a:mi>p</a:mi><a:mo><</a:mo><a:mn>0.001</a:mn></a:math> ), intubation (OR 7.4; 95% CI 4.3 to 12.74, <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"><c:mi>p</c:mi><c:mo><</c:mo><c:mn>0.001</c:mn></c:math> ), LV systolic impairment (OR severe_vs_normal 1.98; 95% CI 1.14 to 3.42, <e:math xmlns:e="http://www.w3.org/1998/Math/MathML" id="M3"><e:mi>p</e:mi><e:mo>=</e:mo><e:mn>0.015</e:mn></e:math> , OR moderate_vs_normal 1.84; 95% CI 1.09 to 3.1, <g:math xmlns:g="http://www.w3.org/1998/Math/MathML" id="M4"><g:mi>p</g:mi><g:mo>=</g:mo><g:mn>0.022</g:mn></g:math> ), serum lactate (OR 1.25; 95% CI 1.12 to 1.41, <i:math xmlns:i="http://www.w3.org/1998/Math/MathML" id="M5"><i:mi>p</i:mi><i:mo><</i:mo><i:mn>0.001</i:mn></i:math> ), base excess (OR 1.1; 95% CI 1.04 to 1.07, <k:math xmlns:k="http://www.w3.org/1998/Math/MathML" id="M6"><k:mi>p</k:mi><k:mo><</k:mo><k:mn>0.001</k:mn></k:math> ), and systolic blood pressure (OR 0.99; 95% CI 0.982 to 0.999, <m:math xmlns:m="http://www.w3.org/1998/Math/MathML" id="M7"><m:mi>p</m:mi><m:mo>=</m:mo><m:mn>0.024</m:mn></m:math> ). The model discrimination was excellent with an area under the curve (AUC) of 0.879 (0.851 to 0.908) ( <o:math xmlns:o="http://www.w3.org/1998/Math/MathML" id="M8"><o:mi>p</o:mi><o:mo><</o:mo><o:mn>0.001</o:mn></o:math> ). Based on these predictors, we created the SAVE (SBP, Arterial blood gas, and left Ventricular Ejection fraction) ACS classification, which showed good discrimination for 30-day AUC 0.814 (0.782 to 0.845) and long-term mortality <q:math xmlns:q="http://www.w3.org/1998/Math/MathML" id="M9"><q:mfenced open="(" close=")" separators="|"><q:mrow><q:msub><q:mrow><q:mi>p</q:mi></q:mrow><q:mrow><q:mi mathvariant="normal">log</q:mi><q:mo>−</q:mo><q:mtext>rank</q:mtext></q:mrow></q:msub><q:mo><</q:mo><q:mn>0.001</q:mn></q:mrow></q:mfenced></q:math> . A similar AUC was demonstrated in the validation cohort (AUC 0.815). Conclusions. In the current study, we introduce a rapid way of classifying CS using frontline parameters. The SAVE ACS classification could allow for future randomized studies to explore the benefit of mechanical circulatory support in different CS stages in ACS patients.
No takes yet. Share an insight, caveat, or question.
Panoulas et al. (2022) conducted a cohort in Acute coronary syndromes (ACS) (n=11,870). SAVE ACS classification was evaluated on 30-day mortality (AUC 0.814, 95% CI 0.782-0.845). The SAVE ACS classification demonstrated good discrimination for predicting 30-day mortality in patients with acute coronary syndromes (AUC 0.814; 95% CI 0.782-0.845).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: